Home › NDC Lookup › RxCUI directory › RxCUI 197363

Amoxapine 100 MG Oral Tablet — RxCUI 197363

RxNorm drug concept · Semantic clinical drug
RxCUI 197363 Semantic clinical drug · SCD ● Current RxNorm concept 8 FDA products 8 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI197363
Official nameAmoxapine 100 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped8
Package NDCs mapped8
Reported Medicaid activity (SDUD)35 prescriptions · 2 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Amoxapine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats depression, including depression with anxiety or agitation. It's used for several types, from reactive depression to psychotic depression. Your prescriber chose it based...
  • Some people feel an effect within 4 to 7 days. For most who respond, it shows within about two weeks. Keep taking it as directed, and don't stop without talking to your prescriber.
  • Take it by mouth exactly as prescribed. You may start with two or three doses a day. Later, you may be able to take it once at bedtime, which also helps with drowsiness.
  • The most common are drowsiness, dry mouth, constipation and blurred vision. Call your doctor if you have seizures, unusual muscle movements, high fever with stiffness, a rash, or t...
📖 Read our full Amoxapine guide →

🕸️ Concept Web — How Amoxapine 100 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Amoxapine 100 MG Oral Tablet RxCUI 197363

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Amoxapine 722
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Amoxapine Oral Tablet 370575
    • Amoxapine Oral Product 1152590
    • Amoxapine Pill 1152591
    • Oral Tablet 317541
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Amoxapine 100 MG 315363

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Amoxapine 100 MG SCDC · 315363
  • Amoxapine Oral Tablet SCDF · 370575
  • Amoxapine Oral Product SCDG · 1152590
  • Amoxapine Pill SCDG · 1152591

📦 FDA Products & Package NDCs

8 products · 8 package NDCs
8 package NDCs map to RxCUI 197363 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00591-5713-01 100 TABLET in 1 BOTTLE, PLASTIC (0591-5713-01) Amoxapine Actavis Pharma, Inc. 1992-08-28
00591-5714-01 100 TABLET in 1 BOTTLE, PLASTIC (0591-5714-01) Amoxapine Actavis Pharma, Inc. 1992-08-28
00591-5715-01 100 TABLET in 1 BOTTLE, PLASTIC (0591-5715-01) Amoxapine Actavis Pharma, Inc. 1992-08-28
00591-5716-30 30 TABLET in 1 BOTTLE, PLASTIC (0591-5716-30) Amoxapine Actavis Pharma, Inc. 1992-08-28
62135-0700-90 90 TABLET in 1 BOTTLE (62135-700-90) Amoxapine Chartwell RX, LLC 2023-09-06
62135-0701-90 90 TABLET in 1 BOTTLE (62135-701-90) Amoxapine Chartwell RX, LLC 2023-09-06
62135-0702-90 90 TABLET in 1 BOTTLE (62135-702-90) Amoxapine Chartwell RX, LLC 2023-09-06
62135-0703-30 30 TABLET in 1 BOTTLE (62135-703-30) Amoxapine Chartwell RX, LLC 2023-09-06
Observed labelers: Actavis Pharma, Inc. (4) · Chartwell RX, LLC (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.